These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Results of a retrospective multicenter trial of the Viatorr expanded polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation. Charon JP, Alaeddin FH, Pimpalwar SA, Fay DM, Olliff SP, Jackson RW, Edwards RD, Robertson IR, Rose JD, Moss JG. J Vasc Interv Radiol; 2004 Nov; 15(11):1219-30. PubMed ID: 15525740 [Abstract] [Full Text] [Related]
3. Early and long-term clinical and radiological follow-up results of expanded-polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunt procedures. Maleux G, Nevens F, Wilmer A, Heye S, Verslype C, Thijs M, Wilms G. Eur Radiol; 2004 Oct; 14(10):1842-50. PubMed ID: 15221261 [Abstract] [Full Text] [Related]
10. TIPS: comparison of shunt patency and clinical outcomes between bare stents and expanded polytetrafluoroethylene stent-grafts. Jung HS, Kalva SP, Greenfield AJ, Waltman AC, Walker TG, Athanasoulis CA, Wicky ST. J Vasc Interv Radiol; 2009 Feb; 20(2):180-5. PubMed ID: 19097918 [Abstract] [Full Text] [Related]
11. Comparison study of Doppler ultrasound surveillance of expanded polytetrafluoroethylene-covered stent versus bare stent in transjugular intrahepatic portosystemic shunt. Huang Q, Wu X, Fan X, Cao J, Han J, Xu L, Li N. J Clin Ultrasound; 2010 Sep; 38(7):353-60. PubMed ID: 20533444 [Abstract] [Full Text] [Related]
12. Favorable clinical outcome using a covered stent following transjugular intrahepatic portosystemic shunt in patients with portal hypertension. Wu X, Ding W, Cao J, Han J, Huang Q, Li N, Li J. J Hepatobiliary Pancreat Sci; 2010 Sep; 17(5):701-8. PubMed ID: 20703849 [Abstract] [Full Text] [Related]
14. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study. Bureau C, Garcia Pagan JC, Layrargues GP, Metivier S, Bellot P, Perreault P, Otal P, Abraldes JG, Peron JM, Rousseau H, Bosch J, Vinel JP. Liver Int; 2007 Aug; 27(6):742-7. PubMed ID: 17617116 [Abstract] [Full Text] [Related]
15. [Comparison of the curative effect of transjugular intrahepatic portosystemic shunt with expanded polytetrafluoroethylene-covered stent and drug combined with gastroscopy as the secondary prevention of esophageal -gastric variceal bleeding in portal hypertension]. Lin ZP, Chen SL, Wang JY, Liu F, Tan Q, Peng QF, Zhao JB. Zhonghua Gan Zang Bing Za Zhi; 2020 Aug 20; 28(8):672-678. PubMed ID: 32911906 [Abstract] [Full Text] [Related]
16. 6-mm shunt transjugular intrahepatic portosystemic shunt in patients with severe liver atrophy and variceal bleeding. Yan H, Xiang Z, Zhao C, Luo S, Liu H, Li M, Huang M. Eur Radiol; 2024 Jul 20; 34(7):4697-4707. PubMed ID: 38006453 [Abstract] [Full Text] [Related]
18. Comparison of Technical and Clinical Outcome of Transjugular Portosystemic Shunt Placement Between a Bare Metal Stent and a PTFE-Stentgraft Device. Lauermann J, Potthoff A, Mc Cavert M, Marquardt S, Vaske B, Rosenthal H, von Hahn T, Wacker F, Meyer BC, Rodt T. Cardiovasc Intervent Radiol; 2016 Apr 20; 39(4):547-56. PubMed ID: 26404629 [Abstract] [Full Text] [Related]
19. Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt. Bai M, He CY, Qi XS, Yin ZX, Wang JH, Guo WG, Niu J, Xia JL, Zhang ZL, Larson AC, Wu KC, Fan DM, Han GH. World J Gastroenterol; 2014 Jan 21; 20(3):774-85. PubMed ID: 24574750 [Abstract] [Full Text] [Related]
20. Current diagnosis and management of post-transjugular intrahepatic portosystemic shunt refractory hepatic encephalopathy. Pereira K, Carrion AF, Martin P, Vaheesan K, Salsamendi J, Doshi M, Yrizarry JM. Liver Int; 2015 Dec 21; 35(12):2487-94. PubMed ID: 26332169 [Abstract] [Full Text] [Related] Page: [Next] [New Search]